Does Dr. JEANETTE ABETRANI DIYORIO have financial conflicts of interest?

Dr. JEANETTE ABETRANI DIYORIO (APRN) has received a total of $2,576 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,576 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JEANETTE ABETRANI DIYORIO?

According to CMS Open Payments data, Dr. JEANETTE ABETRANI DIYORIO received funding from ASTRAZENECA PHARMACEUTICALS ($530), ABBVIE ($376), and NOVO NORDISK ($337).

Does Dr. JEANETTE ABETRANI DIYORIO receive research grants or speaking fees?

Dr. JEANETTE ABETRANI DIYORIO has received $2,576 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JEANETTE ABETRANI DIYORIO

APRNReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: WINTER HAVEN, FL 33881

NPI Number: 1609658384

LIFETIME INDUSTRY VALUE

$2,576

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABETRANI DIYORIO is a verified Nurse Practitioner, Family practitioner based in WINTER HAVEN, FL.

Between 2021 and 2025, Dr. ABETRANI DIYORIO had an overall industry promotional and research financial footprint of $2,576 as recorded in the federal CMS Open Payments database.

$2,576 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABETRANI DIYORIO's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $530 (representing 20.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$530

20.6%

ABBVIE

Rank 2

$376

14.6%

NOVO NORDISK

Rank 3

$337

13.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.